To posture or not to posture after macular hole surgery

Retina

Volumn 28, Issue 1, 2008, Pages 60-65

  Dhawahir Scala, Felipe Eduardo ^a   Maino, Anna ^a   Saha, Konal ^a   Mokashi, Aashish A ^a   McLauchlan, Rita ^a   Charles, Steven ^a  

^a MANCHESTER ROYAL EYE HOSPITAL   (United Kingdom)

Author keywords

Macular hole surgery; Phacovitrectomy; Postoperative face down posture

Indexed keywords

ACETAZOLAMIDE;

ADULT; AGED; ARTICLE; BODY POSTURE; CATARACT; CLINICAL ARTICLE; CONTACT LENS; EYE SURGERY; GAS; HUMAN; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; LENS IMPLANT; OPTICAL COHERENCE TOMOGRAPHY; PATIENT POSITIONING; PHACOEMULSIFICATION; PHACOVITRECTOMY; POSTOPERATIVE PERIOD; PROSPECTIVE STUDY; REFRACTION ERROR; RETINA MACULA HOLE; SURGICAL TECHNIQUE; TREATMENT OUTCOME; VISUAL ACUITY; VITRECTOMY;

AGED; AGED, 80 AND OVER; FEMALE; FLUOROCARBONS; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; PHACOEMULSIFICATION; POSTOPERATIVE CARE; PRONE POSITION; PROSPECTIVE STUDIES; RETINAL PERFORATIONS; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY; VITRECTOMY;

EID: 38049165613     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/IAE.0b013e31813c68a2     Document Type: Article

References (32)

1. Chan A, Duker JS, Schuman JS, et al. Stage 0 macular holes: observations by optical coherence tomography. Ophthalmology 2004;111:2027-2032.
2. Tognetto D, Grandin R, Sanguietti G, et al. Internal limiting membrane removal during macular hole surgery: results of a multicenter retrospective study. Ophthalmology 2006;113:1401-1410.
3. Uemoto R, Yamamoto S, Takeuchi S. Epimacular proliferative response following internal limiting membrane peeling for idiopathic macular holes. Graefes Arch Clin Exp Ophth 2004;242:1777-1780.
4. Funata M, Wendel RT, de la Cruz Z, Green WR. Clinicopathologic study of bilateral macular holes treated with pars plana vitrectomy and gas tamponade. Retina 1992;12:289-298.
5. Madreperla SA, Geiger GL, Funata M, de la Cruz Z, Green WR. Clinicopathologic correlation of a macular hole treated by cortical vitreous peeling and gas tamponade. Ophthalmology 1994;101:682-686.
6. Thompson JT, Smiddy WE, Glaser BM, Sjaarda RN, Flynn HW Jr. Intraocular tamponade duration and success of macular hole surgery. Retina 1996;16:373-382.
7. Ellis JD, Malik TY, Taubert MA, Barr A, Baines PS. Surgery for full-thickness macular holes with short-duration prone posturing: results of a pilot study. Eye 2000;14:307-312.
8. Sato H, Kawasaki R, Yamashita H. Observation of idiopathic full-thickness macular hole closure in early postoperative period as evaluated by optical coherence tomography. Am J Ophthalmol 2003;136:185-187.
9. Verma D, Jalabi MW, Watts WG, Naylor G. Evaluation of posturing in macular hole surgery. Eye 2002;16:701-704.
10. Tornambe PE, Poliner LS, Grote K. Macular hole surgery without face-down positioning. A pilot study. Retina 1997;17:179-185.
11. Simcock PR, Scalia S. Phacovitrectomy without prone posture for full thickness macular holes. Br J Ophthalmol 2001;85:1316-1319.
12. Krohn J. Duration of face-down positioning after macular hole surgery: a comparison between 1 week and 3 days. Acta Ophthalmol Scand 2005;83:289-292.
13. Tranos PG, Peter NM, Nath R, et al. Macular hole surgery without prone positioning. Eye 2007;21:802-806.
14. Jaycock PD, Bunce C, Xing W, et al. Outcomes of macular hole surgery: implications for surgical management and clinical governance. Eye 2005;19:879-884.
15. Park DW, Sipperley JO, Sneed SR, Dugel PU, Jacobsen J. Macular hole surgery with internal-limiting membrane peeling and intravitreous air. Ophthalmology 1999;106:1392-1398.
16. Mester V, Kuhn F. Internal limiting membrane removal in the management of full-thickness macular holes. Am J Ophthalmol 2000;129:769-777.
17. Brooks HL Jr. Macular hole surgery with and without internal limiting membrane peeling. Ophthalmology 2000;107:1939-1949.
18. Kelly NE, Wendel RT. Vitreous surgery for idiopathic macular holes. Results of a pilot study. Arch Ophthalmol 1991;109:654-659.
19. Ryan EH Jr, Gilbert HD. Results of surgical treatment of recent-onset full-thickness idiopathic macular holes. Arch Ophthalmol 1994;112:1545-1553.
20. Thompson JT, Glaser BM, Sjaarda RN, Murphy RP Progression of nuclear sclerosis and long-term visual results of vitrectomy with transforming growth factor beta-2 for macular holes. Am J Ophthalmol 1995;119:48-54.
21. Lansing MB, Glaser BM, Liss H, et al. The effect of pars plana vitrectomy and transforming growth factor-beta 2 without epiretinal membrane peeling on full-thickness macular holes. Ophthalmology 1993;100:868-872.
22. Duker JS, Wendel R, Patel AC, Puliafito CA. Late re-opening of macular holes after initially successful treatment with vitreous surgery. Ophthalmology 1994;101:1373-1378.
23. Miller-Meeks MJ, Simpson JL. Outcomes of cataract extraction in previously vitrectomized eyes for repair of macular holes. Presented at the annual meeting of the American Academy of Ophthalmology; Chicago, Illinois; October 27-31, 1996.
24. Lacalle VD, Garate FJO, Alday NM, Garrido JAL, Agesta JA. Phacoemulsification cataract surgery in vitrectomised eyes. J Cataract Refract Surg 1998;24:806-809.
25. Roth DB, Smiddy WE, Feuer W. Vitreous surgery for chronic macular holes. Ophthalmology 1997;104:2047-2052.
26. Thompson JT, Sjaarda RN, Lansing MB. The results of vitreous surgery for chronic macular holes. Retina 1997;17:493-501.
27. Kang HK, Chang AA, Beaumont PE. The macular hole: report of an Australian surgical series and meta-analysis of the literature. Clin Exp Ophthalmol 2000;28:298-308.
28. Glaser BM, Michels RG, Kuppermann BD, Sjaarda RN, Pena RA. Transforming growth factor-beta 2 for the treatment of full-thickness macular holes. A prospective randomized study. Ophthalmology 1992;99:1162-1173.
29. Smiddy WE, Glaser BM, Thompson JT, et al. Transforming growth factor-beta 2 significantly enhances the ability to flatten the rim of subretinal fluid surrounding macular holes. Preliminary anatomic results of a multicenter prospective randomized study. Retina 1993;13:296-301.
30. Thompson JT, Glaser BM, Sjaarda RN, Murphy RP, Hanham A. Effects of intraocular bubble duration in the treatment of macular holes by vitrectomy and transforming growth factor-beta 2. Ophthalmology 1994;101:1195-200.
31. Liggett PE, Skolik DS, Horio B, Saito Y, Alfaro V, Mieler W. Human autologous serum for the treatment of full-thickness macular holes. A preliminary study. Ophthalmology 1995 ;102:1071-1076.
32. Gaudric A, Massin P, Paques M, et al. Autologous platelet concentrate for the treatment of full-thickness macular holes. Graefes Arch Clin Exp Ophthalmol 1995;233:549-554.